Leal Therapeutics 新闻与活动
高管
查看带有其 14 名主要高管的组织结构图
Leal Therapeutics 搜索最多的简介
- Asa Abeliovich, Chief Executive Officer
- Franz Hefti, Independent Director
- Athena Countouriotis, Chairman of the Board
高管在Leal Therapeutics变化
- Mittie Doyle已作为Senior Manager, Business Development and Operations加入公司 (新闻发布的2025六月24号).
创建提醒
跟踪 Leal Therapeutics 的高管变动
生物技术
Leal Therapeutics 拥有 2,344 家竞争者，其中包括 Eurofins (卢森堡)、Tangram Therapeutics (联合王国) 和 Incyte (美国(美洲))。
Popular M&A news in 生物技术
- Azalea Therapeutics 刚刚宣布为 82 筹款数百万美元。 (公布2025十一月7号).
- AAVantgarde 刚刚宣布为 141 筹款数百万美元。 (公布2025十一月4号).
- Manifold Bio 刚刚宣布为 55 筹款数百万美元。 (公布2025十一月4号).
生物技术 行业的其他推荐联系人
消息
Leal Therapeutics 的最新新闻稿
- Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need - Leal Therapeutics
- Exclusive: Neuro startup Leal raises $30M Series A for schizophrenia and ALS trials
- Exclusive: Top neuroscientist Asa Abeliovich targets ALS, schizophrenia with new startup Leal after $1B Lilly buyout
- Leal Therapeutics Announces $45 Million Financing to Progress Novel Therapies for Patients with Major Neurodegenerative and Neuropsychiatric Disorders - Leal Therapeutics
- Scoop: Star neuroscientist Asa Abeliovich and OrbiMed are teaming on yet another biotech
- News - Leal Therapeutics
- News - Leal Therapeutics
- View more press releases Close
